PRMT5-IN-19 (Compound 41) 是一种具有口服活性的非核苷 PRMT5 选择性抑制剂,其 IC50 值为 23.9 nM (radioactive biochemical assay) 和 47 nM (AlphaLISA assay),可通过占据 PRMT5 中的 SAM-binding pocket 并封闭甲基转移酶活性发挥作用,对 PRMTs 和 PKMTs 的选择性更优,并通过诱导细胞凋亡 (apoptosis) 抑制细胞增殖,可用于癌症相关研究。
产品编号: MS-V33923 CAS No.: 2783961-86-2
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

PRMT5-IN-19 (Compound 41) 是一种具有口服活性的非核苷 PRMT5 选择性抑制剂,其 IC50 值为 23.9 nM (radioactive biochemical assay) 和 47 nM (AlphaLISA assay),可通过占据 PRMT5 中的 SAM-binding pocket 并封闭甲基转移酶活性发挥作用,对 PRMTs 和 PKMTs 的选择性更优,并通过诱导细胞凋亡 (apoptosis) 抑制细胞增殖,可用于癌症相关研究。

生物实验数据

生物活性 PRMT5-IN-19 (Compound 41) is an orally active, non-nucleoside selective PRMT5 inhibitor with IC50 values of 23.9 nM (radioactive biochemical assay) and 47 nM (AlphaLISA assay) that occupies the SAM-binding pocket in PRMT5 and blocks methyltransferase activity, exhibits selectivity over PRMTs and PKMTs, and inhibits cell proliferation by inducing apoptosis, making it suitable for cancer-related research.
IC50 & Target

PRMT5

23.9 nM (IC50)

PRMT1

3.252 μM (IC50)

PRMT4

>20 μM (IC50)

体外研究
(In Vitro)

PRMT5-IN-19 (Compound 41, 5 days) has strong anti-proliferative effects against the A375 cell with an IC50 value of 1.36 μM.
PRMT5-IN-19 shows higher selectivity for PRMT5 (IC50 value of 23.9 nM) than other histone methyltransferases (PRMT1 and PRMT4), and PKMTS (EZH2, NSD2, MLL1, and MLL4).
PRMT5-IN-19 binds with the SAM-binding pocket in PRMT5.
PRMT5-IN-19 (4-5 days) Inhibits proliferation of multiple cancer cell lines (A-375, CHL-1, SNU-423, SNU-449, MDA-MB-231, MDA-MA-453, MV-4-11, MOLM13) with IC50 value ranging from 1.08 to 3.45 μM.
PRMT5-IN-19 inhibits arginine symmetrical dimethylation in A375 cells.
PRMT5-IN-19 (0-4 μM, 48 h) suppresses A375 cell proliferation by inducing apoptosis in a concentration-dependent manner.

Cell Proliferation Assay

Cell Line: A-375, CHL-1, SNU-423, SNU-449, MDA-MB-231, MDA-MA-453, MV-4-11, MOLM13
Concentration: 0-10 μM
Incubation Time: 5 days
Result: Inhibited proliferation of multiple cancer cell lines with IC50 value ranging from 1.08 to 3.45 μM.

Western Blot Analysis

Cell Line: A-375 cells
Concentration: 0.5, 1, 2, 4,8 μM
Incubation Time: 48 h.
Result: Inhibited arginine symmetrical dimethylation in a dose-dependent manner.
体内研究
(In Vivo)

PRMT5-IN-19 (Compound 41, A375 xenograft model, 75 mg/kg/d, p.o., 19 days) has good PK properties and significant antitumor efficacy, without the obvious loss of body weight and visible toxicity.

Animal Model: A375 cell-derived nude mouse xenograft model.
Dosage: 75 mg/kg/d
Administration: P.o., 19 days
Result: Had no effect on the body weight, displayed antitumor efficacy with a tumor growth inhibition (TGI) rate of 73% by inhibiting the methyltransferase activity of PRMT5.
Animal Model: Rats and mice.
Dosage: 10 mg/kg for p.o., 3 mg/kg for i.v
Administration: P.o., i.v. (Pharmacokinetic Analysis)
Result: Pharmacokinetic parameters for PRMT5-IN-19 in SD Rats and Micea,c .
species PRMT5-IN-19 T1/2 (h) Cmax (ng/mL) CL (mL/min/kg) F (%)
rat iv (3 mg/kg)/td> 2.58 310
po (10 mg/kg)/td> 7.51 8.22 7.25
po (10 mg/kg)/td> 2.95 27.7 23.7
mouse iv (3 mg/kg)/td> 4.71 153
po (10 mg/kg)/td> 128
分子量

396.48

Formula

C25H24N4O

CAS 号

2783961-86-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
Data Sheet (537 KB) 产品使用指南 (1538 KB)
参考文献
  • . Deqin Rong, et al. Structure-Aided Design, Synthesis, and Biological Evaluation of Potent and Selective Non-Nucleoside Inhibitors Targeting Protein Arginine Methyltransferase 5. J Med Chem. 2022 Jun 9;65(11):7854-7875.  [Content Brief]

  • . Deqin Rong, et al. Structure-Aided Design, Synthesis, and Biological Evaluation of Potent and Selective Non-Nucleoside Inhibitors Targeting Protein Arginine Methyltransferase 5. J Med Chem. 2022 Jun 9;65(11):7854-7875.

PRMT5-IN-19 相关分类

  • Cancer
  • 肿瘤靶向治疗 肿瘤代谢与转移
  • Epigenetics
  • Histone Methyltransferase
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2

Keywords:

PRMT5-IN-192783961-86-2Histone MethyltransferaseA375 cellSAM-binding pocketmethyltransferasecell apoptosisA375 xenograft modelcancerInhibitorinhibitorinhibit

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础

  • 客服

    2851296953

    18923798467

    微信洽谈